Eli Lilly and Company’s Post

View organization page for Eli Lilly and Company, graphic

1,830,004 followers

What risks can be associated with counterfeit, fake, compounded and other untested or unapproved medicines? Read our open letter to people living with diabetes and obesity, their families and healthcare providers about these potentially serious risks—and why appropriate use of genuine medicines is important. Read more at: https://e.lilly/3VNTFLf

  • No alternative text description for this image

A timely caution to beware the use of fake tirzepatide and semaglutide for cosmetic weight loss!

Like
Reply
Russ Sibley, CSM

Senior Project Manager at TECSYS

1mo

Counterfeit drugs might not be such a problem if Lilly would produce mounjaro to meet the needs of diabetics. TWO MONTHS AND I STILL CANNOT FIND THE DRUG. I am the NORMAL, NOT THE EXCEPTION. CVS claims they are unable to fulfill my prescription, no supply can be found. People are desperate and clutch at counterfeits in urgent need of the drug. How is it possible no Mounjaro can be found. A personal thought is Lilly is diverting the drug to their weight loss drug because they make more money. Why is this drug going to celebrities for vanity weight loss when diabetics need it to save their life.

Like
Reply
Tahnya R

Senior Regulatory Compliance Specialist at Health Canada | PMP | Author

1mo

When I worked with counterfeit drugs at the border we were finding many of these pills (sildenafil being a big one), were being manufactured in people's basements. Guess what they used as a binder - GLUE. And for color - PAINT. 😲 I can't believe people would ingest this.

Unfortunately people are looking for opinions to get the medication since it’s impossible to get approved by insurance companies and or approved and if you have a PO come July it’s nul and void this medicine is not only beneficial for many ailments besides diabetes and is helping so many people #letsmakeiteasytoget

USA and international Research .

Chief Executive Officer at USA and International Research Inc.

1mo

Important message about the risks of counterfeit and unapproved medicines. Ensuring safety through genuine medications is crucial for diabetes and obesity management. 

Like
Reply

We should find a way to make the medicine available to everyone so they don’t have to look for an alternative medicine and possibly get fake compound medication

Like
Reply
Darren Nelson 🚀 (We're hiring)

Innovative Leadership in Talent Solutions: Founder & CEO of Recruits Lab & BioJobs Lab, Driving Organizational Success through Cutting-Edge Recruitment Strategies.

1mo

Thank you for raising awareness on this critical issue, Eli Lilly and Company. It's crucial for everyone to understand the risks associated with counterfeit and unapproved medicines. Ensuring access to genuine, tested medications is paramount for patient safety and well-being. #PatientSafety #HealthcareAwareness

Like
Reply

Importancia en asegurarse en la marca legible, etiqueta, cierres de los medicamentos. Constatar información en la página de Entidad regulatoria y en la página de la Oficina de Propiedad Intelectual (marcas y patentes)

GREAT! Your open letter can provide useful information for avoiding various risks. The way how to distinguish from fake products is clearly shown by photo and checkpoints. Very helpful.

Like
Reply

Post this with the NYTimes and other big media.

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics